PL2470546T3 - Związki heksahydrooksazynopterydynowe do zastosowania jako inhibitory MTOR - Google Patents
Związki heksahydrooksazynopterydynowe do zastosowania jako inhibitory MTORInfo
- Publication number
- PL2470546T3 PL2470546T3 PL10749736T PL10749736T PL2470546T3 PL 2470546 T3 PL2470546 T3 PL 2470546T3 PL 10749736 T PL10749736 T PL 10749736T PL 10749736 T PL10749736 T PL 10749736T PL 2470546 T3 PL2470546 T3 PL 2470546T3
- Authority
- PL
- Poland
- Prior art keywords
- hexahydrooxazinopteridine
- compounds
- mtor inhibitors
- mtor
- inhibitors
- Prior art date
Links
- QCXCHXZKOUVUJT-UHFFFAOYSA-N 3,4,4a,5,5a,8-hexahydro-1H-oxazino[3,4-g]pteridine Chemical class N1OCCC2C1=NC1=CN=CNC1N2 QCXCHXZKOUVUJT-UHFFFAOYSA-N 0.000 title 1
- 229940124302 mTOR inhibitor Drugs 0.000 title 1
- 239000003628 mammalian target of rapamycin inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US23806409P | 2009-08-28 | 2009-08-28 | |
| US31360810P | 2010-03-12 | 2010-03-12 | |
| EP10749736.4A EP2470546B1 (en) | 2009-08-28 | 2010-08-26 | Hexahydrooxazinopteridine compounds for use as mtor inhibitors |
| PCT/US2010/046839 WO2011025889A1 (en) | 2009-08-28 | 2010-08-26 | HEXAHYDROOXAZINOPTERINE COMPOUNDS FOR USE AS mTOR INHIBITORS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2470546T3 true PL2470546T3 (pl) | 2013-12-31 |
Family
ID=42768136
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL10749736T PL2470546T3 (pl) | 2009-08-28 | 2010-08-26 | Związki heksahydrooksazynopterydynowe do zastosowania jako inhibitory MTOR |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US8163755B2 (pl) |
| EP (1) | EP2470546B1 (pl) |
| JP (1) | JP2013503183A (pl) |
| AR (1) | AR077974A1 (pl) |
| DK (1) | DK2470546T3 (pl) |
| ES (1) | ES2432315T3 (pl) |
| HR (1) | HRP20130951T1 (pl) |
| PL (1) | PL2470546T3 (pl) |
| PT (1) | PT2470546E (pl) |
| SI (1) | SI2470546T1 (pl) |
| TW (1) | TW201119656A (pl) |
| UY (1) | UY32863A (pl) |
| WO (1) | WO2011025889A1 (pl) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101763656B1 (ko) | 2009-06-29 | 2017-08-01 | 인사이트 홀딩스 코포레이션 | Ｐｉ3ｋ 저해물질로서의 피리미디논 |
| US8759359B2 (en) | 2009-12-18 | 2014-06-24 | Incyte Corporation | Substituted heteroaryl fused derivatives as PI3K inhibitors |
| RU2012131124A (ru) | 2009-12-23 | 2014-01-27 | Элан Фармасьютикалз, Инк. | Птеридиноны как ингибиторы polo-подобных киназ |
| EP2558463A1 (en) | 2010-04-14 | 2013-02-20 | Incyte Corporation | Fused derivatives as i3 inhibitors |
| WO2011163195A1 (en) | 2010-06-21 | 2011-12-29 | Incyte Corporation | Fused pyrrole derivatives as pi3k inhibitors |
| EP3660016A1 (en) | 2010-12-20 | 2020-06-03 | Incyte Holdings Corporation | N-(1-(substituted-phenyl)ethyl)-9h-purin-6-amines as pi3k inhibitors |
| MX343706B (es) | 2011-01-31 | 2016-11-18 | Novartis Ag | Derivados heterocíclicos novedosos. |
| US9295673B2 (en) | 2011-02-23 | 2016-03-29 | Intellikine Llc | Combination of mTOR inhibitors and P13-kinase inhibitors, and uses thereof |
| US8791107B2 (en) | 2011-02-25 | 2014-07-29 | Takeda Pharmaceutical Company Limited | N-substituted oxazinopteridines and oxazinopteridinones |
| US9108984B2 (en) | 2011-03-14 | 2015-08-18 | Incyte Corporation | Substituted diamino-pyrimidine and diamino-pyridine derivatives as PI3K inhibitors |
| WO2012135009A1 (en) | 2011-03-25 | 2012-10-04 | Incyte Corporation | Pyrimidine-4,6-diamine derivatives as pi3k inhibitors |
| PT3513793T (pt) | 2011-09-02 | 2021-05-10 | Incyte Holdings Corp | Heterociclilaminas como inibidores de pi3k |
| PT2771342T (pt) | 2011-10-28 | 2016-08-17 | Novartis Ag | Derivados de purina e o seu uso no tratamento de doença |
| AR090548A1 (es) | 2012-04-02 | 2014-11-19 | Incyte Corp | Azaheterociclobencilaminas biciclicas como inhibidores de pi3k |
| JP6280546B2 (ja) | 2012-06-26 | 2018-02-14 | デル マー ファーマシューティカルズ | ジアンヒドロガラクチトール、ジアセチルジアンヒドロガラクチトール、ジブロモズルシトール、又はこれらの類似体若しくは誘導体を用いた、遺伝子多型又はａｈｉ１の調節不全若しくは変異を有する患者におけるチロシンキナーゼインヒビター抵抗性悪性腫瘍を処置するための方法 |
| CA2881322A1 (en) | 2012-09-10 | 2014-03-13 | F. Hoffmann-La Roche Ag | 6-amino acid heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection |
| TWI687220B (zh) | 2013-03-01 | 2020-03-11 | 美商英塞特控股公司 | 吡唑并嘧啶衍生物治療PI3Kδ相關病症之用途 |
| WO2014153509A1 (en) | 2013-03-22 | 2014-09-25 | Millennium Pharmaceuticals, Inc. | Combination of catalytic mtorc 1/2 inhibitors and selective inhibitors of aurora a kinase |
| KR20160061911A (ko) | 2013-04-08 | 2016-06-01 | 데니스 엠. 브라운 | 최적하 투여된 화학 화합물의 치료 효과 |
| CN112472699A (zh) | 2013-07-26 | 2021-03-12 | 种族肿瘤学公司 | 改善比生群及衍生物的治疗益处的组合方法 |
| CN105636962B (zh) * | 2013-10-15 | 2017-10-13 | 靳博涵 | 新型化合物、用途及其制备方法 |
| SI3129021T1 (sl) | 2014-04-08 | 2021-07-30 | Incyte Corporation | Zdravljenje malignosti B-celic s kombinacijo zaviralcev JAK in PI3K |
| WO2015191677A1 (en) | 2014-06-11 | 2015-12-17 | Incyte Corporation | Bicyclic heteroarylaminoalkyl phenyl derivatives as pi3k inhibitors |
| SG10201907576SA (en) | 2015-02-27 | 2019-09-27 | Incyte Corp | Salts of pi3k inhibitor and processes for their preparation |
| US9988401B2 (en) | 2015-05-11 | 2018-06-05 | Incyte Corporation | Crystalline forms of a PI3K inhibitor |
| US9732097B2 (en) | 2015-05-11 | 2017-08-15 | Incyte Corporation | Process for the synthesis of a phosphoinositide 3-kinase inhibitor |
| US20160362424A1 (en) | 2015-05-11 | 2016-12-15 | Incyte Corporation | Salts of (s)-7-(1-(9h-purin-6-ylamino)ethyl)-6-(3-fluorophenyl)-3-methyl-5h-thiazolo[3,2-a]pyrimidin-5-one |
| KR102017676B1 (ko) * | 2018-03-09 | 2019-09-03 | 연세대학교 원주산학협력단 | 익상편 예방 및 치료용 조성물 |
| SG11202011680YA (en) | 2018-06-01 | 2020-12-30 | Incyte Corp | Dosing regimen for the treatment of pi3k related disorders |
| WO2020076728A1 (en) * | 2018-10-08 | 2020-04-16 | Takeda Pharmaceutical Company Limited | SUBSTITUTED OXAZINOPTERIDINONES AS INHIBITORS OF mTOR |
| GB202415232D0 (en) | 2024-10-16 | 2024-11-27 | Nacamed As | Composition |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003076440A1 (en) | 2002-03-06 | 2003-09-18 | Smithkline Beecham Corporation | Condensed heterocyclic compounds as calcitonin agonists |
| GB0415364D0 (en) | 2004-07-09 | 2004-08-11 | Astrazeneca Ab | Pyrimidine derivatives |
| EP1846410B1 (en) | 2005-02-10 | 2009-01-21 | Bristol-Myers Squibb Company | Dihydroquinazolinones as 5ht modulators |
| US8911498B2 (en) | 2005-02-10 | 2014-12-16 | DePuy Synthes Products, LLC | Intervertebral prosthetic disc |
| EP2057129A1 (en) | 2006-08-24 | 2009-05-13 | AstraZeneca AB | Morpholino pyrimidine derivatives useful in the treatment of proliferative disorders |
| US7928100B2 (en) | 2007-10-05 | 2011-04-19 | Cylene Pharmaceuticals, Inc. | Quinolone analogs and methods related thereto |
| US20090149458A1 (en) * | 2007-11-27 | 2009-06-11 | Wyeth | PYRROLO[3,2-d]PYRIMIDINE COMPOUNDS AND THEIR USE AS PI3 KINASE AND mTOR KINASE INHIBITORS |
| CN103403010A (zh) * | 2010-10-08 | 2013-11-20 | 依兰制药公司 | Polo样激酶的抑制剂 |
-
2010
- 2010-08-26 HR HRP20130951AT patent/HRP20130951T1/hr unknown
- 2010-08-26 AR ARP100103122A patent/AR077974A1/es unknown
- 2010-08-26 US US12/869,452 patent/US8163755B2/en active Active
- 2010-08-26 PL PL10749736T patent/PL2470546T3/pl unknown
- 2010-08-26 EP EP10749736.4A patent/EP2470546B1/en not_active Not-in-force
- 2010-08-26 WO PCT/US2010/046839 patent/WO2011025889A1/en not_active Ceased
- 2010-08-26 DK DK10749736.4T patent/DK2470546T3/da active
- 2010-08-26 JP JP2012526992A patent/JP2013503183A/ja not_active Ceased
- 2010-08-26 ES ES10749736T patent/ES2432315T3/es active Active
- 2010-08-26 SI SI201030392T patent/SI2470546T1/sl unknown
- 2010-08-26 PT PT107497364T patent/PT2470546E/pt unknown
- 2010-08-27 TW TW099128976A patent/TW201119656A/zh unknown
- 2010-08-27 UY UY0001032863A patent/UY32863A/es not_active Application Discontinuation
-
2012
- 2012-03-26 US US13/429,865 patent/US8268819B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20110053921A1 (en) | 2011-03-03 |
| HRP20130951T1 (hr) | 2013-11-22 |
| JP2013503183A (ja) | 2013-01-31 |
| WO2011025889A1 (en) | 2011-03-03 |
| EP2470546B1 (en) | 2013-07-24 |
| TW201119656A (en) | 2011-06-16 |
| AR077974A1 (es) | 2011-10-05 |
| ES2432315T3 (es) | 2013-12-02 |
| EP2470546A1 (en) | 2012-07-04 |
| US20120178924A1 (en) | 2012-07-12 |
| UY32863A (es) | 2011-03-31 |
| SI2470546T1 (sl) | 2013-12-31 |
| US8268819B2 (en) | 2012-09-18 |
| DK2470546T3 (da) | 2013-10-14 |
| US8163755B2 (en) | 2012-04-24 |
| PT2470546E (pt) | 2013-10-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2470546T3 (pl) | Związki heksahydrooksazynopterydynowe do zastosowania jako inhibitory MTOR | |
| IL216145A0 (en) | Dihydropyrimidinones for use as bace2 inhibitors | |
| IL215297A0 (en) | Imidazopyrazines for use as kinase inhibitors | |
| ZA201202703B (en) | Synthetic methods for spiro-oxindole compounds | |
| GB0906472D0 (en) | New compounds | |
| GB0906470D0 (en) | New compounds | |
| IL213992A0 (en) | Pro-neurogenic compounds | |
| IL215147A0 (en) | Compounds | |
| ZA201206410B (en) | Polyheterocylic compounds highly potent as hcv inhibitors | |
| GB0907425D0 (en) | Compounds | |
| IL220154A0 (en) | Novel pyrimidine compounds as mtor and pi3k inhibitors | |
| EP2393493A4 (en) | LINKS | |
| ZA201203662B (en) | Compounds | |
| GB0907515D0 (en) | Compounds | |
| ZA201400374B (en) | 4-piperidinyl compounds for use as tankyrase inhibitors | |
| EP2416657A4 (en) | COMPOUNDS COMPRISING SUBSTITUTED DI-ARYLHYDANTOIDS AND DI-ARYLTHIOHYDANTOINES AND METHODS OF USE THEREOF | |
| ZA201108131B (en) | Dihydroorotate- dehydrogenasee inhibitors as virostatic compounds | |
| GB0914856D0 (en) | Compounds | |
| EP2519508A4 (en) | METALLO ENZYME INHIBITOR COMPOUNDS | |
| IL220701A0 (en) | Tricyclic compounds for use as kinase inhibitors | |
| GB0922302D0 (en) | Compounds | |
| GB0900388D0 (en) | New compounds | |
| GB0905641D0 (en) | Compounds | |
| GB0903493D0 (en) | New compounds | |
| GB201004372D0 (en) | Compounds for purification |